| Product NDC: | 44087-1150 |
| Proprietary Name: | Ovidrel |
| Non Proprietary Name: | choriogonadotropin alfa |
| Active Ingredient(s): | 250 ug/.5mL & nbsp; choriogonadotropin alfa |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 44087-1150 |
| Labeler Name: | EMD Serono, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021149 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20031006 |
| Package NDC: | 44087-1150-1 |
| Package Description: | 1 SYRINGE, GLASS in 1 CARTON (44087-1150-1) > .5 mL in 1 SYRINGE, GLASS |
| NDC Code | 44087-1150-1 |
| Proprietary Name | Ovidrel |
| Package Description | 1 SYRINGE, GLASS in 1 CARTON (44087-1150-1) > .5 mL in 1 SYRINGE, GLASS |
| Product NDC | 44087-1150 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | choriogonadotropin alfa |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20031006 |
| Marketing Category Name | NDA |
| Labeler Name | EMD Serono, Inc. |
| Substance Name | CHORIOGONADOTROPIN ALFA |
| Strength Number | 250 |
| Strength Unit | ug/.5mL |
| Pharmaceutical Classes | Gonadotropin [EPC],Gonadotropins [Chemical/Ingredient] |